X
Thinking niche: the challenge of pharma’s focus on small patient populations
https://pharmaphorum.com/white-papers/thinking-niche-the-challenge-of-pharmas-focus-on-small-patient-populations/
Brexit
Brexit makes UK pharma market less attractive – can a more collaborative culture redeem it?
A UK market access summit convened by IQVIA brought together pharma and NHS leaders to look at how working more closely – including more outcomes-based deals – could help UK life sciences through Brexit and beyond.
Drug Delivery West
Meeting the design needs of drug delivery systems
GSK welcomes Brexit transition deal, but wants more ‘precision’ on final relationship
The chief executive of GlaxoSmithKline has welcomed the breakthrough in talks between the UK and EU27 countries on a transition or ‘implementation’ period.
GSK expects Brexit admin to cost £70m
Like the rest of pharma, GSK prepares for the worst
Despite ‘no pick and mix’ warning, pharma’s Brexit planners still hope for deal
The chairman of a pan-European pharma group says he is still optimistic that a Brexit deal can be struck, despite the head of the European Council rejecting British plans for future alignment.
